pyruvaldehyde has been researched along with zinc oxide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alomary, MN; Alzohairy, MA; Anandan, S; Ansari, MA; Chikkamadaiah, M; Farha Siraj, S; Halugudde Nagaraja, S; Ledesma, AE; Mahadevamurthy, M; Nagaraj, AK; Naguvanahalli Krishnappa, HK; Thimappa Ramachandrappa, L; Urooj, A | 1 |
| Al Obaid, S; Alahmadi, TA; Balaji, MP; Brindhadevi, K; Chakraborty, S; Govindasamy, R; Karuppusamy, I; Lan Chi, NT; Sengani, M; V, DR | 1 |
2 other study(ies) available for pyruvaldehyde and zinc oxide
| Article | Year |
|---|---|
Biosynthesized ZnO-NPs from
Topics: Animals; Cattle; Diabetes Mellitus, Experimental; Erythrocytes; Glycation End Products, Advanced; Hyperglycemia; Male; Molecular Docking Simulation; Morus; Nanoparticles; Pyruvaldehyde; Rats; Rats, Wistar; Serum Albumin, Bovine; Streptozocin; Zinc Oxide | 2019 |
Anti-diabetic efficacy and selective inhibition of methyl glyoxal, intervention with biogenic Zinc oxide nanoparticle.
Topics: Animals; Diabetes Mellitus; Glycation End Products, Advanced; Magnesium Oxide; Nanoparticles; Pyruvaldehyde; Rats; Rats, Wistar; Zinc Oxide | 2023 |